MediMabBio is actively seeking strategic partnerships at JPM2026.
MediMabBio is an innovative biotherapeutics company specializing in the discovery and development of novel anti-cancer and autoimmune disease immunotherapies. Our discovery efforts are driven by global research partnerships with renowned academic, R&D, and clinical institutions in the US, UK, and Korea.
Address
Seongnam-siGyeonggi-do
South Korea
